ESR1 and breast cancer: Breast cancer is a heterogenous disease with multiple subtypes that display distinct risk factor patterns with differences between estrogen receptor (ER)/progesterone receptor (PR) positive (ER+PR+) versus those that are negative for ER/PR [8–10].